The Adenosine A2A-Receptor Antagonist Istradefylline Enhances the Motor Response of l-DOPA Without Worsening Dyskinesia in MPTP-Treated Common Marmosets
The adenosine A2A-receptor antagonist istradefylline decreases OFF time in patients with Parkinson’s disease who are already treated with optimal doses of dopaminergic medication but can cause an increase in non-troublesome dyskinesia. Preclinical experiments have shown that A2A antagonists are most...
Main Authors: | Shin-ichi Uchida, Tomomi Tashiro, Mika Kawai-Uchida, Akihisa Mori, Peter Jenner, Tomoyuki Kanda |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-01-01
|
Series: | Journal of Pharmacological Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861319301707 |
Similar Items
-
The pharmacological manipulation of L-DOPA-induced dyskinesia in the MPTP-treated marmoset model of Parkinson's disease
by: Banerji, Tara
Published: (2002) -
Morphological changes in serotoninergic neurites in the striatum and globus pallidus in levodopa primed MPTP treated common marmosets with dyskinesia
by: Bai-Yun Zeng, et al.
Published: (2010-12-01) -
Behavioural and biochemical investigations into dyskinesia by levodopa or dopamine agonists in the MPTP-treated common marmoset
by: Maratos, Eleni Chryssa
Published: (2002) -
The effect of adenosine A2A receptor antagonist istradefylline on multiple organ dysfunction in heatstroke rats
by: Chih-Chin Shih, et al.
Published: (2020-01-01) -
Zonisamide Attenuates MPTP Neurotoxicity in Marmosets
by: Mohammed Emamussalehin Choudhury, et al.
Published: (2010-01-01)